Read more

GlycoMimetics CFO Testifies Before House Capital Markets Subcommittee on Behalf of BIO

 

Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial Services, Subcommittee on Capital Markets, Securities, and Investment. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee.

 

Hahn’s testimony highlighted the successes of the Jumpstart Our Business Startups (JOBS) Act across the biotech industry. In the six years since the JOBS Act was enacted, 260 emerging biotechnology companies have used provisions in the law to go public.

 

Full release here:
https://www.businesswire.com/news/home/20180523006308/en/Biotech-Leader-Testifies-House-Capital-Markets-Subcommittee